Transcranial magnetic stimulation in schizophrenia.
Yu
Hseih-Chiao
HC
Liao
Kwong-Kum
KK
Chang
Ta-Jen
TJ
Tsai
Shih-Jen
SJ
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D003071:Cognition / Q000502:physiology; D003131:Combined Modality Therapy; D018913:Event-Related Potentials, P300 / Q000502:physiology; D005260:Female; D005625:Frontal Lobe / Q000737:chemistry; D006801:Humans; D006966:Hyperprolactinemia / Q000097:blood / Q000139:chemically induced; D008297:Male; D011388:Prolactin / Q000097:blood; D011985:Receptors, Serotonin / Q000032:analysis; D012559:Schizophrenia / Q000097:blood / Q000188:drug therapy / Q000628:therapy*; D050781:Transcranial Magnetic Stimulation / Q000627:therapeutic use*
D014150:Antipsychotic Agents; D011985:Receptors, Serotonin; D011388:Prolactin